Clinical Trial Update: Diagnostic Biomarkers for Checkpoint Inhibitor-related Pneumonitis

View source ↗

Summary

This clinical trial aims to identify diagnostic biomarkers for pneumonitis related to immune checkpoint inhibitors and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonitis

Snippet

Sponsor: Zhou Chengzhi | Conditions: Checkpoint Inhibitor-related Pneumonitis | Status: RECRUITING